The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Scrambler therapy for treatment of chemotherapy-induced peripheral neuropathy.
Breanna L Weisbrod
No relevant relationships to disclose
Deirdre R. Pachman
No relevant relationships to disclose
Drew K. Seisler
No relevant relationships to disclose
Debra L. Barton
No relevant relationships to disclose
Kelliann C. Fee-Schroeder
No relevant relationships to disclose
Thomas J. Smith
No relevant relationships to disclose
Daniel Honore Lachance
No relevant relationships to disclose
Heshan Liu
No relevant relationships to disclose
Andrea L. Cheville
No relevant relationships to disclose
Charles L. Loprinzi
Research Funding - Competitive Technologies